PROGRESS20 May 2024 17:21
Laura I have leant that its best to exercise patience with the Board of PYC . On matters pertaining to ValaiRx I was extremely unhappy years ago that Gene Ice was transferred away from PYC as I believed at the time it was an very important holding in the PYC portfolio and an excellent fit. That said I won't hold my breath on 201 its just a bonus if it happens. We tried to buy ValiRx when it was worth nothing a few years ago but were thwarted in our attempts though provided enough incite to others that was sufficient to enable its steady progress on the market and fundability. I did say that I was not surprised that Board members were not buying They currently receive a lot less in comparison to AIM directors generally and haven't awarded themselves bucket loads of options either. I think we will soon get notification of both contract sign offs, an update on the new BioStats Division and quite possibly an indication of successful outcomes from the conferences. As I have said previously PYC are in the right space at the right time Lets give PS a chance to prove himself rather than second guess, as at least one negative poster is hell bent on doing. News will soon propel the share price as with all AIM stocks and we are very undervalued irrespective recent announcements by the company. I am more than happy to defend their position and the Company's future which in my opinion if bright.